Show Stocks and Investing Publications • Fri, March 3, 2023
Patrick Trucchio Maintained (ALNY) at Strong Buy and Held Target at $415 on, Mar 3rd, 2023
io-maintained-alny-at-strong-buy-and-held-target-at-415-on-mar-3rd-2023.html
Stocks and Investing on Mon, Oct 28th, 2024Patrick Trucchio of HC Wainwright & Co., Maintained "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $415 on, Mar 3rd, 2023.
Patrick has made no other calls on ALNY in the last 4 months.
There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $205 on, Friday, February 24th, 2023
- Mani Foroohar of "SVB Leerink" Maintained at Hold with Decreased Target to $143 on, Monday, January 23rd, 2023
These are the ratings of the 7 analyists that currently disagree with Patrick
- Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Friday, February 24th, 2023
- Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Friday, February 24th, 2023
- Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $249 on, Friday, February 24th, 2023
- David Lebovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $265 on, Friday, February 24th, 2023
- Michael King of "EF Hutton" Reiterated at Strong Buy and Held Target at $304 on, Friday, February 24th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $291 on, Friday, February 24th, 2023
- Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $253 on, Friday, December 16th, 2022